What You Should Know:

What You Should Know:

QuantHealth, an AI-powered clinical trial design company that simulates clinical trials, announced the appointment of Dr. Adam Petrich, MD, as the company’s inaugural Chief Medical Officer and Adam Goldberger as Chief Financial Officer.

– As QuantHealth’s first Chief Financial Officer, Adam Goldberger will partner with the executive team to help drive innovation and reach critical financial milestones as the company continues commercializing its platform and expanding its roster of industry partners. 

In his role as Chief Medical Officer, Dr. Adam Petrick, MD will focus on enhancing product offerings and capabilities, providing oversight and guidance to the R&D teams, and leading all outward-facing clinically-oriented interactions. 

Dr. Adam Petrick, MD Background

Dr. Petrich, a medical oncologist and hematologist by training, has spent the last ten years in oncology drug development, including tenures of increasing responsibility at Daiichi-Sankyo and AbbVie, across various platforms and phases of clinical development. Prior to that, he was a full-time faculty member at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University in Chicago. 

Adam Goldberger Background

Prior to QuantHealth, Adam spent more than two decades in various capacities within the private and public sectors, working for companies across Israel, The United States, and Australia. Most recently, he acted as Chief Business Officer at RenalSense and CFO/Group Executive at MedHealth.